Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294.SZ)
CNY 32.71
(-0.58%)
CNY 32.71
(-0.58%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 490.85 Million CNY | -9.69% |
| 2022 | 543.53 Million CNY | 29.27% |
| 2021 | 420.45 Million CNY | 7.38% |
| 2020 | 391.55 Million CNY | -22.18% |
| 2019 | 503.15 Million CNY | -11.86% |
| 2018 | 570.88 Million CNY | 19.47% |
| 2017 | 477.84 Million CNY | 47.74% |
| 2016 | 323.44 Million CNY | -5.02% |
| 2015 | 340.54 Million CNY | 124.22% |
| 2014 | 151.88 Million CNY | -5.35% |
| 2013 | 160.47 Million CNY | -28.94% |
| 2012 | 225.82 Million CNY | 34.19% |
| 2011 | 168.28 Million CNY | -25.25% |
| 2010 | 225.13 Million CNY | 49.62% |
| 2009 | 150.47 Million CNY | 51.43% |
| 2008 | 99.36 Million CNY | 33.78% |
| 2007 | 74.27 Million CNY | 63.99% |
| 2006 | 45.29 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 457.27 Million CNY | -6.84% |
| 2024 Q2 | 471.81 Million CNY | 3.18% |
| 2024 Q3 | 487.88 Million CNY | 3.41% |
| 2023 Q4 | 490.85 Million CNY | 3.73% |
| 2023 Q3 | 473.19 Million CNY | -3.25% |
| 2023 Q2 | 489.06 Million CNY | -7.12% |
| 2023 FY | 490.85 Million CNY | -9.69% |
| 2023 Q1 | 526.57 Million CNY | -3.12% |
| 2022 Q1 | 452.84 Million CNY | 7.7% |
| 2022 FY | 543.53 Million CNY | 29.27% |
| 2022 Q4 | 543.53 Million CNY | 17.07% |
| 2022 Q3 | 464.29 Million CNY | -6.0% |
| 2022 Q2 | 493.9 Million CNY | 9.07% |
| 2021 Q1 | 412.03 Million CNY | 5.23% |
| 2021 FY | 420.45 Million CNY | 7.38% |
| 2021 Q4 | 420.45 Million CNY | 10.6% |
| 2021 Q3 | 380.15 Million CNY | -8.19% |
| 2021 Q2 | 414.06 Million CNY | 0.49% |
| 2020 Q4 | 391.55 Million CNY | -2.33% |
| 2020 Q1 | 488.04 Million CNY | -3.0% |
| 2020 FY | 391.55 Million CNY | -22.18% |
| 2020 Q3 | 400.89 Million CNY | -3.79% |
| 2020 Q2 | 416.69 Million CNY | -14.62% |
| 2019 Q2 | 559.84 Million CNY | 5.2% |
| 2019 Q1 | 532.14 Million CNY | -6.79% |
| 2019 FY | 503.15 Million CNY | -11.86% |
| 2019 Q4 | 503.15 Million CNY | -4.93% |
| 2019 Q3 | 529.22 Million CNY | -5.47% |
| 2018 Q4 | 570.88 Million CNY | 5.32% |
| 2018 Q3 | 542.05 Million CNY | 7.57% |
| 2018 FY | 570.88 Million CNY | 19.47% |
| 2018 Q2 | 503.9 Million CNY | 1.97% |
| 2018 Q1 | 494.14 Million CNY | 3.41% |
| 2017 Q3 | 504.95 Million CNY | 14.17% |
| 2017 Q2 | 442.27 Million CNY | 15.17% |
| 2017 FY | 477.84 Million CNY | 47.74% |
| 2017 Q4 | 477.84 Million CNY | -5.37% |
| 2017 Q1 | 384.03 Million CNY | 18.73% |
| 2016 FY | 323.44 Million CNY | -5.02% |
| 2016 Q4 | 323.44 Million CNY | 10.82% |
| 2016 Q1 | 260.72 Million CNY | -23.44% |
| 2016 Q3 | 291.86 Million CNY | 19.77% |
| 2016 Q2 | 243.68 Million CNY | -6.53% |
| 2015 Q4 | 340.54 Million CNY | -0.69% |
| 2015 FY | 340.54 Million CNY | 124.22% |
| 2015 Q3 | 342.91 Million CNY | 32.67% |
| 2015 Q1 | 192.95 Million CNY | 27.04% |
| 2015 Q2 | 258.47 Million CNY | 33.96% |
| 2014 Q4 | 151.88 Million CNY | -7.16% |
| 2014 Q1 | 164.19 Million CNY | 2.32% |
| 2014 Q3 | 163.6 Million CNY | -2.43% |
| 2014 FY | 151.88 Million CNY | -5.35% |
| 2014 Q2 | 167.67 Million CNY | 2.12% |
| 2013 Q1 | 245.4 Million CNY | 8.67% |
| 2013 FY | 160.47 Million CNY | -28.94% |
| 2013 Q4 | 160.47 Million CNY | -27.05% |
| 2013 Q3 | 219.96 Million CNY | -9.33% |
| 2013 Q2 | 242.59 Million CNY | -1.15% |
| 2012 Q4 | 225.82 Million CNY | 34.38% |
| 2012 FY | 225.82 Million CNY | 34.19% |
| 2012 Q1 | 156.7 Million CNY | -6.88% |
| 2012 Q2 | 190.69 Million CNY | 21.69% |
| 2012 Q3 | 168.04 Million CNY | -11.88% |
| 2011 Q1 | 208.44 Million CNY | -7.41% |
| 2011 Q3 | 181.46 Million CNY | -22.93% |
| 2011 FY | 168.28 Million CNY | -25.25% |
| 2011 Q4 | 168.28 Million CNY | -7.26% |
| 2011 Q2 | 235.45 Million CNY | 12.96% |
| 2010 Q2 | 201.5 Million CNY | 19.13% |
| 2010 Q1 | 169.14 Million CNY | 12.41% |
| 2010 Q4 | 225.13 Million CNY | 5.97% |
| 2010 FY | 225.13 Million CNY | 49.62% |
| 2010 Q3 | 212.45 Million CNY | 5.43% |
| 2009 Q3 | 135.22 Million CNY | 34.37% |
| 2009 FY | 150.47 Million CNY | 51.43% |
| 2009 Q2 | 100.64 Million CNY | 0.0% |
| 2009 Q4 | 150.47 Million CNY | 11.27% |
| 2008 Q4 | 99.36 Million CNY | 0.0% |
| 2008 FY | 99.36 Million CNY | 33.78% |
| 2007 FY | 74.27 Million CNY | 63.99% |
| 2006 FY | 45.29 Million CNY | 0.0% |